Lamotrigine Tablet
Product Images NDC 0904-7007

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 0904-7007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A8e89916 Ae5a 48af 9da1 8b9288d977fd 388 2

Lamotrigine 100 mg oral tablet with imprint code 'ZC 79' on one side. The round, white tablet is designed for oral use and is part of the Major Pharmaceuticals label set.*

FDA Label Image

Dce2a594 1357 4ba8 Ab8a D7adc9132c5b 00

Lamotrigine 100 mg oral tablets unit dose package label by Major Pharmaceuticals. The label indicates 100 tablets per unit dose, with instructions for pharmacists to dispense with a medication guide and warnings to keep out of reach of children. Storage is recommended at controlled room temperature 20 to 25°C (68 to 77°F). The label includes NDC 0904-7008-61 and distributor information for Major Pharmaceuticals in Livonia, MI.*

FDA Label Image

Dce2a594 1357 4ba8 Ab8a D7adc9132c5b 01

Lamotrigine 25 mg oral tablets packaging label from Major Pharmaceuticals. The label indicates a unit dose with 100 tablets per package, featuring caution to verify the product dispensed and instructions for pharmacists to dispense with a medication guide. Storage instructions and warnings are provided on the label, along with manufacturer and distributor information.*

FDA Label Image

Dce2a594 1357 4ba8 Ab8a D7adc9132c5b 02

Lamotrigine 100 mg round white tablet imprint ZC 80 on one side. Oral tablet manufactured by Major Pharmaceuticals.*

FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 01

Chemical structure of Lamotrigine, showing a triazine ring with two amino groups and a dichlorophenyl group attached, consistent with the molecular structure of the drug Lamotrigine.*

FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 02

A line graph comparing failure probability (%) over weeks for Lamotrigine versus placebo. The x-axis represents weeks from 0 to 100, and the y-axis shows failure probability from 0% to 100%. Two curves are displayed: one labeled 'Lamotrigine' with a generally lower failure probability over time, and another labeled 'Placebo' with a higher failure probability, including censored data points indicated by marks along the lines.*

FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 03

A Kaplan-Meier failure probability plot comparing Lamotrigine and placebo over approximately 80 weeks. The y-axis represents failure probability in percentage, and the x-axis represents time in weeks. The chart shows two stepwise curves marked for 'Lamotrigine' and 'Placebo,' with censored data points indicated. The Lamotrigine curve generally shows lower failure probability than placebo across the timeframe.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.